CUTR INVESTOR DEADLINE

Robbins Geller Rudman & Dowd LLP Announces that Cutera, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Cutera, Inc. (NASDAQ: CUTR) common stock between February 17, 2021 and May 9, 2023, both dates inclusive (the “Class Period”) have until July 24, 2023 to seek appointment as lead plaintiff of the Cutera class action lawsuit. Captioned Erie County Employees’ Retirement System v. Cutera, Inc., No. 23-cv-02560 (N.D. Cal.), the Cutera class action lawsuit charges Cutera and certain of its top executives and directors with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the Cutera class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-cutera-inc-class-action-lawsuit-cutr.htm ...

You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at [e-mail].

CASE ALLEGATIONS: Cutera is a medical aesthetic device company that provides equipment for beauty treatments.

The Cutera class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Cutera overstated the sustainability of its revenue growth; (ii) there were significant conflicts among members of Cutera’s senior leadership and Board of Directors; and (iii) there were several material weaknesses in Cutera’s internal control of financial reporting.

On January 9, 2023, Cutera revealed that Cutera had failed to meet its revenue guidance for 2022. On this news, the price of Cutera common stock declined more than 23%.

Then, on February 28, 2023, Cutera disclosed that Cutera would not be able to timely file its annual financial report by the March 1, 2023 deadline. Cutera also disclosed that it identified material weaknesses in its internal control over financial reporting related to ineffective inventory count controls. On this news, the price of Cutera common stock declined further.

Thereafter, on March 16, 2023, Cutera announced it would not meet the extended deadline for filing its 2022 annual report. Cutera also revealed that, in addition to the material weaknesses previously identified, Cutera had identified material weaknesses related to stock-based compensation. On this news, the price of Cutera common stock declined more than 12%.

A week later, on March 24, 2023, Cutera disclosed that Nasdaq notified it that it was “not in compliance with Nasdaq Listing Rule 5250(c)(1)” for failing to timely file its 2022 annual financial report. On this news, the price of Cutera common stock decline more than 3%.